🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this research is to understand if the medication called FEIB...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-10
Trial ID
NCT05020483
This is a randomized, open label, placebo-controlled, parallel design, sing...
Status
Completed
Location
PRA Health Sciences
Start Date
2021-11-12
Trial ID
NCT05205863
Treatments Being Tested
This study aims to assess a fixed-dose regimen of activated prothrombin com...
Status
Completed
Location
Multiple Locations
Start Date
2015-10
Trial ID
NCT02565836
In order to evaluate the diagnostic and prognostic value of thrombin-antith...
Status
Unknown
Location
Multiple Locations
Start Date
2024-04-20
Trial ID
NCT06379126
To demonstrate that the efficacy of OCTAPLEX as a reversal agent in patient...
Status
Completed
Location
Octapharma Research Site
Start Date
2017-06-08
Trial ID
NCT02740335
Treatments Being Tested
The goal of this study is to determine if a fixed dose of 4-factor prothrom...
Status
Completed
Location
Regions Hospital
Start Date
2017-04-05
Trial ID
NCT03064035
Treatments Being Tested
Patients on oral anticoagulants need rapid reversal of the anticoagulant ef...
Status
Completed
Location
Clinical Trials Registration Coordinator
Start Date
2005-09
Trial ID
NCT00168077
Treatments Being Tested
Primary Objective: -To evaluate the efficacy of fitusiran compared to on-d...
Status
Completed
Location
Investigational Site Number 0140
Start Date
2018-03-01
Trial ID
NCT03417245
Treatments Being Tested
This study is conducted globally. The aim of this study is to describe the ...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2005-10
Trial ID
NCT01779921
The purpose of this dose-ranging pilot study is to compare Recombinant Acti...
Status
Terminated
Location
Multiple Locations
Start Date
2008-04
Trial ID
NCT00770718
Treatments Being Tested